Celularity (CELU) Assets (2018 - 2025)
Celularity's (CELU) quarterly Assets came in at $336000.0 in Q4 2025, down 99.75% year-over-year from $132.7 million in Q4 2024, and down 99.71% quarter-over-quarter from $114.2 million in Q3 2025.
Analysis
Celularity (CELU) Assets (2018 - 2025) Analysis & Trends
Celularity (CELU) has reported Assets for 8 consecutive years, with $336000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Assets fell 99.75% year-over-year to $336000.0 in Q4 2025; TTM through Dec 2025 was $336000.0, a 99.75% decrease from a year earlier, with the FY2025 full-year figure at $336000.0, down 99.75% from the prior year.
- Assets was $336000.0 for Q4 2025 at Celularity, down from $114.2 million in the prior quarter.
- Over five years, Assets peaked at $448.3 million in Q3 2021 and troughed at $336000.0 in Q4 2025.
- A 5-year average of $239.9 million and a median of $150.5 million in 2023 frame the typical range for Assets.
- Across the five-year window, Assets surged 234.33% in 2022 and tumbled 99.75% in 2025, its largest moves.
- Over 5 years, Assets stood at $414.1 million in 2021, then decreased by 3.15% to $401.1 million in 2022, then tumbled by 64.12% to $143.9 million in 2023, then slipped by 7.79% to $132.7 million in 2024, then plunged by 99.75% to $336000.0 in 2025.
- The last three Assets figures came in at $336000.0 (Q4 2025), $114.2 million (Q3 2025), and $120.3 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.24 Bn | 9.40 Bn | 112.79 Mn | 1.50 Bn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 2.65 Bn |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn | 915.53 Mn |
| 4 | Legend Biotech | 3.55 Bn | 2.59 Bn | 251.50 Mn | 1.75 Bn |
| 5 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn | 985.10 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | 1.39 Bn |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 170.30 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 3.19 Bn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 502.87 Mn |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | 336,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 336,000.00 |
| Sep 30, 2025 | 114.24 Mn |
| Jun 30, 2025 | 120.28 Mn |
| Mar 31, 2025 | 128.88 Mn |
| Dec 31, 2024 | 132.68 Mn |
| Sep 30, 2024 | 128.84 Mn |
| Jun 30, 2024 | 135.49 Mn |
| Mar 31, 2024 | 143.82 Mn |
| Dec 31, 2023 | 143.89 Mn |
| Sep 30, 2023 | 157.19 Mn |
| Jun 30, 2023 | 246.42 Mn |
| Mar 31, 2023 | 362.42 Mn |
| Dec 31, 2022 | 401.07 Mn |
| Sep 30, 2022 | 437.12 Mn |
| Jun 30, 2022 | 429.34 Mn |
| Mar 31, 2022 | 434.20 Mn |
| Dec 31, 2021 | 414.13 Mn |
| Sep 30, 2021 | 448.29 Mn |
| Jun 30, 2021 | 128.42 Mn |
| Mar 31, 2021 | 291.93 Mn |